Michael Watson Ii, PHD | |
3604 Central Ave, Ste C, Hot Springs, AR 71913-6403 | |
(501) 623-9220 | |
(501) 623-9227 |
Full Name | Michael Watson Ii |
---|---|
Gender | Male |
Speciality | Psychologist |
Location | 3604 Central Ave, Hot Springs, Arkansas |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1154861284 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
103T00000X | Psychologist | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Michael Watson Ii, PHD 10025 W Markham St, Suite 210, Little Rock, AR 72205-1407 Ph: (501) 663-5473 | Michael Watson Ii, PHD 3604 Central Ave, Ste C, Hot Springs, AR 71913-6403 Ph: (501) 623-9220 |
News Archive
New research from King's College London published in EBioMedicine, has found that a newly tested medical device, called Sleeveballoon, mimics the effects of traditional bariatric surgery in rodents and produces impressive results on body weight, fatty liver and diabetes control.
Triphase Accelerator Corporation today announced that marizomib, its novel, potent proteasome inhibitor, has been granted orphan drug designation by the U.S. Food and Drug Administration's Office of Orphan Products Development for the treatment of multiple myeloma. The orphan drug designation will provide Triphase with 7-year marketing exclusivity for marizomib and other benefits upon FDA approval.
Air pollution caused by traffic near the home affects asthma severity in children, resulting in repeated hospital encounters according to a study published this month in Annals of Allergy, Asthma & Immunology , the scientific journal of the American College of Allergy, Asthma and Immunology (ACAAI).
Cynosure, Inc., a leader in laser- and light-based treatments for minimally invasive and non-invasive aesthetic applications, today announced the closing of its previously announced underwritten registered public offering of class A common stock.
In many biological and pathological processes, glycosidase enzymes attack glycosidic bonds in carbohydrates, glycoproteins, and glycolipids. The ability to modify or block these processes by specific glycosidase inhibitors forms the basis for their potential use in the treatment of viral infections, cancer, and genetic disorders.
› Verified 9 days ago
Janet Ellen L'abbe, PH D Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1321 Central Ave, Hot Springs, AR 71901 Phone: 757-469-8989 | |
Dr. Connie Kay Venhaus, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 105 Reserve St, Hot Springs, AR 71901 Phone: 501-701-6213 Fax: 501-622-6623 | |
Mr. James (jim) Hood Mcdonald, M.S. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 105 Reserve St, Hot Springs, AR 71901 Phone: 501-624-4411 Fax: 501-622-6623 | |
Dr. James G. Vasilos, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 125 Dons Way, Hot Springs, AR 71913 Phone: 501-624-7111 Fax: 501-620-5109 | |
Tina Marie Emerson, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 5703 Central Ave, #11, Hot Springs, AR 71913 Phone: 501-520-5019 | |
Dr. Carolyn Ann Mckamey, PSY.D. Psychologist Medicare: Medicare Enrolled Practice Location: 320 Ouachita Ave Suite 212, Hot Springs, AR 71901 Phone: 870-819-1556 |